Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis Surgeries
BackgroundSurgical therapy of breast cancer and bone metastasis can effectively improve the prognosis of breast cancer. However, after the first operation, the relationship between preoperative indicators and outcomes in patients who underwent metastatic bone surgery remained to be studied. Purpose...
Main Authors: | Haochen Mou, Zhan Wang, Wenkan Zhang, Guoqi Li, Hao Zhou, Eloy Yinwang, Fangqian Wang, Hangxiang Sun, Yucheng Xue, Zenan Wang, Tao Chen, Xupeng Chai, Hao Qu, Peng Lin, Wangsiyuan Teng, Binghao Li, Zhaoming Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.693689/full |
Similar Items
-
Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
by: Zenan Wang, et al.
Published: (2019-05-01) -
Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
by: Zhan Wang, et al.
Published: (2018-06-01) -
Th9 Cell Differentiation and Its Dual Effects in Tumor Development
by: Tao Chen, et al.
Published: (2020-05-01) -
Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates
by: Shengdong Wang, et al.
Published: (2018-02-01) -
T–cell–based immunotherapy for osteosarcoma: challenges and opportunities
by: Zhan Wang, et al.
Published: (2016-09-01)